UniQure, Syndax, Erasca Drawing Fresh Analyst Interest
Three clinical-stage biotechs—UniQure, Syndax, and Erasca—are catching analyst attention ahead of key catalysts, with...
Compares the volatility characteristics of risk parity against index funds in retirement planning, highlighting stability and risk exposure.
27,630 articlesThree clinical-stage biotechs—UniQure, Syndax, and Erasca—are catching analyst attention ahead of key catalysts, with...
U.S. authorities charged the co-founder of Super Micro Computer and two associates in a $2.5 billion scheme to ship s...
In May, a calmer approach can shine. This article highlights two dividend stocks that are no-brainer buys for conserv...
When Warren Buffett's successor Greg Abel took the helm, Berkshire Hathaway signaled a new phase. This article breaks...
A focused look at the BOSC 2026 earnings transcript for Q1. This article breaks down revenue trends, margin health, a...
Adobe has fallen sharply in 2026, prompting a rotation debate toward Alphabet as AI momentum and big-cap investments ...
Broadcom is pursuing a bold AI compute strategy that could reshape its growth trajectory. This article breaks down th...
KBW argues United Wholesale Mortgage could emerge stronger after failing to win Two Harbors, with faster debt reducti...
A Sea Limited executive sold $4.4 million in stock but remains one of the company’s biggest stakeholders. This piece ...
SoFi Technologies could be on the verge of a significant rerating as revenue and members keep growing. This guide div...
As XRP weathered a months-long retreat, new regulatory wins, steady ETF inflows, and surging on-chain activity are fu...
Dell Technologies shares rose about 5% as Super Micro Computer slumped up to 27% intraday after prosecutors charged a...